DNA (STOCKS)
Ginkgo Bioworks Holdings, Inc.
$7.215000
+0.005000 (+0.07%)
Prev close: $7.210000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Jason Kelly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $464.22M
- Employees
- 834
- P/E (TTM)
- -1.33
- P/B (TTM)
- 1.04
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
2
Hold
5
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.75 | $-0.92 | +0.1691 | +18.40% |
|
Mar 2026 (Q1)
|
$-1.39 | $-1.09 | -0.2992 | -27.43% |
|
Dec 2025 (Q4)
|
$-1.41 | $-1.47 | +0.0596 | +4.06% |
|
Sep 2025 (Q3)
|
$-1.45 | $-1.25 | -0.1976 | -15.78% |
Financial Statements
| Revenues | $111.86M |
| Benefits Costs and Expenses | $407.34M |
| Costs And Expenses | $403.93M |
| Operating Expenses | $397.74M |
| Depreciation and Amortization | $54.03M |
| Research and Development | $215.61M |
| Other Operating Expenses | $143.35M |
| Operating Income/Loss | -$290.69M |
| Income/Loss From Continuing Operations After Tax | -$294.89M |
| Income/Loss From Continuing Operations Before Tax | -$295.48M |
| Income/Loss From Equity Method Investments | -$4.67M |
| Income Tax Expense/Benefit | -$594.00K |
| Net Income/Loss | -$290.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$290.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$290.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.00 |
| Basic Average Shares | 117,010,751 |
| Assets | $990.05M |
| Current Assets | $332.54M |
| Noncurrent Assets | $657.51M |
| Fixed Assets | $157.19M |
| Intangible Assets | $44.39M |
| Other Non-current Assets | $455.94M |
| Liabilities | $569.76M |
| Current Liabilities | $72.74M |
| Accounts Payable | $9.58M |
| Other Current Liabilities | $63.17M |
| Noncurrent Liabilities | $497.02M |
| Equity | $420.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $420.28M |
| Liabilities And Equity | $990.05M |
| Net Cash Flow From Operating Activities | -$170.24M |
| Net Cash Flow From Operating Activities, Continuing | -$178.36M |
| Net Cash Flow From Investing Activities | $56.50M |
| Net Cash Flow From Investing Activities, Continuing | $56.50M |
| Net Cash Flow From Financing Activities | $34.55M |
| Net Cash Flow From Financing Activities, Continuing | $34.55M |
| Exchange Gains/Losses | -$145.00K |
| Net Cash Flow | -$79.34M |
| Net Cash Flow, Continuing | -$87.31M |
| Comprehensive Income/Loss | -$291.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$291.51M |
| Other Comprehensive Income/Loss | -$703.00K |